Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an announcement.
WuXi AppTec Co., Ltd. announced the successful completion of placing 73,800,000 new H shares under a General Mandate, raising net proceeds of HK$7.65 billion. The funds will primarily be used to accelerate global expansion and capacity construction, with a smaller portion allocated for general corporate purposes, reflecting the company’s strategic focus on growth and strengthening its market position.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company focuses on providing comprehensive laboratory and manufacturing services to support the global pharmaceutical, biotechnology, and medical device industries.
Average Trading Volume: 7,999,501
Technical Sentiment Signal: Buy
Current Market Cap: HK$286.6B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.